COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe - EPA:CRI - FR0000130692 - Common Stock
9.66 EUR
0 (0%)
CRI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 15 industry peers in the Industrial Conglomerates industry. CRI may be in some trouble as it scores bad on both profitability and health. CRI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year CRI was profitable.
CRI had a positive operating cash flow in the past year.
Of the past 5 years CRI 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: CRI reported negative operating cash flow in multiple years.
1.2 Ratios
CRI's Return On Assets of 0.26% is on the low side compared to the rest of the industry. CRI is outperformed by 66.67% of its industry peers.
CRI has a Return On Equity of 0.96%. This is in the lower half of the industry: CRI underperforms 66.67% of its industry peers.
CRI has a Return On Invested Capital of 5.19%. This is comparable to the rest of the industry: CRI outperforms 60.00% of its industry peers.
CRI had an Average Return On Invested Capital over the past 3 years of 4.65%. This is below the industry average of 6.68%.
The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.19%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.26% | ||
| ROE | 0.96% | ||
| ROIC | 5.19% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
CRI has a Profit Margin of 0.34%. This is in the lower half of the industry: CRI underperforms 66.67% of its industry peers.
In the last couple of years the Profit Margin of CRI has declined.
The Operating Margin of CRI (6.46%) is comparable to the rest of the industry.
CRI's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 28.51%, CRI is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.46% | ||
| PM (TTM) | 0.34% | ||
| GM | 28.51% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRI is destroying value.
Compared to 1 year ago, CRI has more shares outstanding
The number of shares outstanding for CRI has been increased compared to 5 years ago.
CRI has a better debt/assets ratio than last year.
2.2 Solvency
CRI has an Altman-Z score of 1.23. This is a bad value and indicates that CRI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.23, CRI is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
The Debt to FCF ratio of CRI is 131.84, which is on the high side as it means it would take CRI, 131.84 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CRI (131.84) is worse than 73.33% of its industry peers.
CRI has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CRI (1.38) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 131.84 | ||
| Altman-Z | 1.23 |
ROIC/WACC0.8
WACC6.48%
2.3 Liquidity
A Current Ratio of 1.30 indicates that CRI should not have too much problems paying its short term obligations.
CRI has a worse Current ratio (1.30) than 93.33% of its industry peers.
A Quick Ratio of 0.86 indicates that CRI may have some problems paying its short term obligations.
CRI has a Quick ratio of 0.86. This is in the lower half of the industry: CRI underperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 146.24% over the past year.
CRI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.59% yearly.
Looking at the last year, CRI shows a small growth in Revenue. The Revenue has grown by 6.67% in the last year.
The Revenue has been growing slightly by 3.10% on average over the past years.
EPS 1Y (TTM)146.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 32.48% on average per year.
Based on estimates for the next years, CRI will show a small growth in Revenue. The Revenue will grow by 4.12% on average per year.
EPS Next Y46.67%
EPS Next 2Y52.98%
EPS Next 3Y32.48%
EPS Next 5YN/A
Revenue Next Year3.88%
Revenue Next 2Y5.15%
Revenue Next 3Y4.12%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 80.50, which means the current valuation is very expensive for CRI.
Based on the Price/Earnings ratio, CRI is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
CRI is valuated expensively when we compare the Price/Earnings ratio to 25.46, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.35, the valuation of CRI can be described as very reasonable.
CRI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CRI is cheaper than 80.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.39. CRI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.5 | ||
| Fwd PE | 9.35 |
4.2 Price Multiples
CRI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRI is cheaper than 73.33% of the companies in the same industry.
73.33% of the companies in the same industry are cheaper than CRI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 75.14 | ||
| EV/EBITDA | 7.08 |
4.3 Compensation for Growth
CRI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CRI's earnings are expected to grow with 32.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.72
PEG (5Y)N/A
EPS Next 2Y52.98%
EPS Next 3Y32.48%
5. Dividend
5.1 Amount
CRI has a Yearly Dividend Yield of 1.32%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.64, CRI is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.44, CRI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.32% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CRI pays out 128.00% of its income as dividend. This is not a sustainable payout ratio.
DP128%
EPS Next 2Y52.98%
EPS Next 3Y32.48%
EPA:CRI (11/19/2025, 7:00:00 PM)
9.66
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners5.35%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap240.44M
Revenue(TTM)727.50M
Net Income(TTM)2.50M
Analysts75
Price Target13.09 (35.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.32% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP128%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-40.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.07%
Revenue NY rev (3m)-3.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.5 | ||
| Fwd PE | 9.35 | ||
| P/S | 0.33 | ||
| P/FCF | 75.14 | ||
| P/OCF | 10.28 | ||
| P/B | 0.92 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.08 |
EPS(TTM)0.12
EY1.24%
EPS(NY)1.03
Fwd EY10.7%
FCF(TTM)0.13
FCFY1.33%
OCF(TTM)0.94
OCFY9.73%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)1.72
PEG (5Y)N/A
Graham Number5.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.26% | ||
| ROE | 0.96% | ||
| ROCE | 7.08% | ||
| ROIC | 5.19% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 13.23% | ||
| OM | 6.46% | ||
| PM (TTM) | 0.34% | ||
| GM | 28.51% | ||
| FCFM | 0.44% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexgc growth 3Y-6.3%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 131.84 | ||
| Debt/EBITDA | 4.62 | ||
| Cap/Depr | 65.16% | ||
| Cap/Sales | 2.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30% | ||
| Profit Quality | 128% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 1.23 |
F-Score7
WACC6.48%
ROIC/WACC0.8
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)146.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y46.67%
EPS Next 2Y52.98%
EPS Next 3Y32.48%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year3.88%
Revenue Next 2Y5.15%
Revenue Next 3Y4.12%
Revenue Next 5YN/A
EBIT growth 1Y57.72%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year118.91%
EBIT Next 3Y41.15%
EBIT Next 5YN/A
FCF growth 1Y109.04%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y241.82%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%
COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ
What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.
Can you provide the valuation status for COMPAGNIE CHARGEURS INVEST?
ChartMill assigns a valuation rating of 4 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Fairly Valued.
What is the profitability of CRI stock?
COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.
What is the financial health of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.
Can you provide the expected EPS growth for CRI stock?
The Earnings per Share (EPS) of COMPAGNIE CHARGEURS INVEST (CRI.PA) is expected to grow by 46.67% in the next year.